Skip to main content
Caplight Logo









Scinus Cell Expansion

Scinus Cell Expansion

Private
ZeistHealthcare & Life Scienceshttps://www.scinus.com/

Last Round

Strategic

Mar 10, 2026

Total Funding Raised

$3.49M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Scinus Cell Expansion is a biotechnology company that develops and distributes a bioreactor technology platform for stem cell cultivation, intended to make cell therapies accessible globally.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Biotechnology, Clinical Trials, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

cell therapy manufacturingautomated bioreactorcell expansionsingle-use bioreactorGMP manufacturingcell and gene therapyCGT manufacturingautomated cell culturebenchtop bioreactorbiomanufacturingclosed system bioreactorbioprocessingsingle-use consumableslow-shear cell cultureprocess development servicesMSC expansionT-cell expansion

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scinus Cell Expansion Comparables

Compare Scinus Cell Expansion with similar companies based on industry and business-model similarity.

Scinus Cell Expansion comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aglaris
88%
BioThrust
87%
Astraveus
85%

Scinus Cell Expansion Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMar 10, 2026
StrategicJun 13, 2019

Key People

Founding team and executive leadership

Erik Vossenaar

CEO & Executive Director

Executive Team

Scinus Cell Expansion Investors

Notable investors and investment history

Scinus Cell Expansion investors
InvestorRounds
Myosotis InvestmentsStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 10, 2026

    Raised $3.5M led by Myosotis Investments

  • Dec 25, 2025

    Grew 23% QoQ from 13 to 16 employees.

Scinus Cell Expansion Filings

Explore SEC and related filing metadata, where available.

Scinus Cell Expansion filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Scinus Cell Expansion's valuation, stock price, and market status.

Is Scinus Cell Expansion a public or private company?

Scinus Cell Expansion is a private company.

What is the current stock price of Scinus Cell Expansion?

Scinus Cell Expansion is a private company with no public stock price. No recent secondary market data is available.

How much is Scinus Cell Expansion worth (valuation)?

Valuation information for Scinus Cell Expansion is not publicly available.

Can I buy Scinus Cell Expansion stock?

Scinus Cell Expansion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Scinus Cell Expansion's last funding round?

Scinus Cell Expansion's most recent funding round was Strategic on March 10, 2026.

Who are the main investors in Scinus Cell Expansion?

Key investors in Scinus Cell Expansion include Myosotis Investments.

Will Scinus Cell Expansion IPO soon?

No public IPO plans have been announced for Scinus Cell Expansion.

How can I track Scinus Cell Expansion secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Scinus Cell Expansion's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersZeist
Employee Range12
Year Founded2016
Last FundingMar 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?